On Monday, TransUnion got a positive adjustment to its Relative Strength (RS) Rating, from 68 to 71.
When To Sell Stocks To Lock In Profits And Minimize Losses
IBD's proprietary rating identifies market leadership with a 1 (worst) to 99 (best) score. The grade shows how a stock's price behavior over the last 52 weeks holds up against all the other stocks in our database.
Decades of market research shows that the market's biggest winners tend to have an RS Rating north of 80 as they begin their largest price moves. See if TransUnion can continue to show renewed price strength and clear that threshold.
TransUnion has moved more than 5% past an 81.65 entry in a first-stage consolidation, meaning it's now out of a proper buy range. Look for the stock to create a new chance to pick up shares like a three-weeks tight or pullback to the 50-day or 10-week line.
The company showed 14% earnings growth in its most recent report, while sales growth came in at 7%. The next quarterly numbers are expected on or around Jul. 24.
TransUnion earns the No. 18 rank among its peers in the Financial Services-Specialty industry group. X Financial ADR, IREN and Jiayin Group ADR are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
